Replies to post #414595 on Anavex Life Sciences Corp (AVXL)

[crescentmotor]

if some other drug turns up that treats or prevents Alzheimer's as successfully, and as inexpensively and with no side effects as blarcamesine, Anavex will have real competition.

Did you see the new research supporting/confirming, and adding additional information about the MOA of SAVA's Simufilam and how it boosted another drug's efficacy? The Street liked what it saw. Pay attention to the CMS results this fall. That will likely be a deal changer for SAVA--one way or the other.